Percutaneous Coronary Intervention
Patients with coronary artery disease benefit from a highly skilled team of cardiologists called interventional cardiologists, nurses and technicians. Percutaneous coronary interventions or angioplasty procedures open arteries with catheters. Charles J. Davidson, MD, Medical Director of the Center for Coronary disease and the Cardiac Catheterization Laboratory,
is a recognized leader in the use of a variety of PCI treatments
resulting in long lasting and minimally invasive treatment choices.
The Cardiac Catheterization Laboratory at the Bluhm Cardiovascular Institute was one of the first to reasearch and adopt the use of metal implants coated with special medications, called drug eluting stents. These special stents prevent unwanted growth of cells which can cause the artery to narrow. Now more than 80 percent of patients receive a drug eluting stent resulting in a treatment that is long lasting.
At this time coronary artery disease cannot be cured. Certain patients with added diseases like diabetes or high blood pressure can experience more rapid progression or worsening of coronary artery disease. Interventional cardiologists Dr. Charles Davidson, Mark Ricciardi, MD, Keith Benzuly, MD, Nirat Beohar, MD, Sheridan Meyers, MD, are collaborative leaders in research that focuses on identifying the best and longest lasting treatments for patients with coronary artery disease.
Contact
For more information regarding
percutaneous coronary intervention and the treatments available through
the Center for Coronary Disease, call the Bluhm Cardiovascular
Institute at (866) 662-8467, or request an appointment online.
